| 商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| METHOCARBAMOL | 040413 | 002 | ANDA | METHOCARBAMOL | TABLET;ORAL | 750MG | No | No | 2003/03/17 | 2003/03/17 | ABLE | Discontinued |
| METHOCARBAMOL | 090200 | 001 | ANDA | METHOCARBAMOL | TABLET;ORAL | 500MG | No | No | 2009/11/06 | 2009/11/06 | HETERO LABS LTD III | Prescription |
| METHOCARBAMOL | 090200 | 002 | ANDA | METHOCARBAMOL | TABLET;ORAL | 750MG | No | No | 2009/11/06 | 2009/11/06 | HETERO LABS LTD III | Prescription |
| METHOCARBAMOL | 200958 | 001 | ANDA | METHOCARBAMOL | TABLET;ORAL | 500MG | No | No | 2011/10/21 | 2011/10/21 | HANGZHOU BINJIANG | Prescription |
| METHOCARBAMOL | 200958 | 002 | ANDA | METHOCARBAMOL | TABLET;ORAL | 750MG | No | No | 2011/10/21 | 2011/10/21 | HANGZHOU BINJIANG | Prescription |
| METHOCARBAMOL | 200958 | 003 | ANDA | METHOCARBAMOL | TABLET;ORAL | 1GM | No | Yes | 2011/10/21 | 2021/12/06 | HANGZHOU BINJIANG | Prescription |
| METHOCARBAMOL | 204404 | 001 | ANDA | METHOCARBAMOL | SOLUTION;IM-IV | 1GM/10ML (100MG/ML) | No | No | 2014/12/05 | 2014/12/05 | MYLAN INSTITUTIONAL | Discontinued |
| METHOCARBAMOL | 206128 | 001 | ANDA | METHOCARBAMOL | SOLUTION;IM-IV | 1GM/10ML (100MG/ML) | No | No | 2016/05/27 | 2016/05/27 | EUGIA PHARMA | Prescription |
| METHOCARBAMOL | 205354 | 001 | ANDA | METHOCARBAMOL | SOLUTION;IM-IV | 1GM/10ML (100MG/ML) | No | No | 2016/10/27 | 2016/10/27 | MONTEREY PHARMS LLC | Prescription |
| METHOCARBAMOL | 208116 | 001 | ANDA | METHOCARBAMOL | SOLUTION;IM-IV | 1GM/10ML (100MG/ML) | No | No | 2017/01/19 | 2017/01/19 | SLATE RUN PHARMA | Prescription |
| METHOCARBAMOL | 203550 | 001 | ANDA | METHOCARBAMOL | TABLET;ORAL | 500MG | No | No | 2017/02/08 | 2017/02/08 | DBL PHARMS | Prescription |
| METHOCARBAMOL | 203550 | 002 | ANDA | METHOCARBAMOL | TABLET;ORAL | 750MG | No | No | 2017/02/08 | 2017/02/08 | DBL PHARMS | Prescription |
| METHOCARBAMOL | 207496 | 001 | ANDA | METHOCARBAMOL | SOLUTION;IM-IV | 1GM/10ML (100MG/ML) | No | No | 2017/06/22 | 2017/06/22 | AM REGENT | Prescription |
| METHOCARBAMOL | 205404 | 001 | ANDA | METHOCARBAMOL | SOLUTION;IM-IV | 1GM/10ML (100MG/ML) | No | No | 2017/07/18 | 2017/07/18 | SAGENT PHARMS INC | Prescription |
| METHOCARBAMOL | 208507 | 001 | ANDA | METHOCARBAMOL | TABLET;ORAL | 500MG | No | No | 2017/07/21 | 2017/07/21 | BEXIMCO PHARMS USA | Prescription |
| METHOCARBAMOL | 208507 | 002 | ANDA | METHOCARBAMOL | TABLET;ORAL | 750MG | No | No | 2017/07/21 | 2017/07/21 | BEXIMCO PHARMS USA | Prescription |
| METHOCARBAMOL | 207522 | 001 | ANDA | METHOCARBAMOL | SOLUTION;IM-IV | 1GM/10ML (100MG/ML) | No | No | 2017/07/31 | 2017/07/31 | SOMERSET THERAPS LLC | Prescription |
| METHOCARBAMOL | 206071 | 001 | ANDA | METHOCARBAMOL | SOLUTION;IM-IV | 1GM/10ML (100MG/ML) | No | No | 2017/11/24 | 2017/11/24 | NAVINTA LLC | Prescription |
| METHOCARBAMOL | 209331 | 001 | ANDA | METHOCARBAMOL | SOLUTION;IM-IV | 1GM/10ML (100MG/ML) | No | No | 2018/04/17 | 2018/04/17 | FRESENIUS KABI USA | Prescription |
| METHOCARBAMOL | 209312 | 001 | ANDA | METHOCARBAMOL | TABLET;ORAL | 500MG | No | Yes | 2018/05/07 | 2018/05/07 | GRANULES | Prescription |